Mechanisms of Smell Improvement With Dupilumab.

NCT05964465 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG: Dupilumab

Sponsor

Medical University of South Carolina